Toripalimab combined with chemoradiotherapy for patients with locally advanced cervical squamous cell carcinoma.

Authors

Dan Ou

Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

Dan Ou , Haoping Xu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Cervical Cancer

Clinical Trial Registration Number

ChiCTR2000032879

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 5538)

DOI

10.1200/JCO.2022.40.16_suppl.5538

Abstract #

5538

Poster Bd #

417

Abstract Disclosures

FEATURED

Toripalimab combined with chemoradiotherapy for patients with locally advanced cervical squamous cell carcinoma.

Authors

Dan Ou

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Poster Details

Meeting

Session Type

Session Title

Track

Sub Track

Clinical Trial Registration Number

Citation

DOI

Abstract #

Poster Bd #

Similar Posters

Poster

Randomized controlled trial of the efficacy of lymph node dissection on stage IIICr of cervical cancer (CQGOG0103).

Poster

CALLA: Efficacy and safety of durvalumab with and following concurrent chemoradiotherapy (CCRT) versus CCRT alone in women with locally advanced cervical cancer-A phase III, randomized, double-blind, multicenter study.

Poster

Suboptimal regimens in sequential treatment (ST) with ICT (induction chemotherapy) followed by CCRT (concomitant chemotherapy) in "real life" patients with locally advanced pharyngo-laryngeal squamous-cell carcinoma (LAPLSCC) and prognosis.

Poster

Induction therapy of toripalimab combined with docetaxel and cisplatin in locally advanced hypopharyngeal squamous cell carcinoma (HPSCC): A single-arm, phase II clinical trial.